Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Chem Phys Lipids ; 184: 52-60, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25454361

ABSTRACT

Afri et al. (2014a,b) have recently reported their mapping of DMPC liposomes using (13)C NMR in conjunction with a wide range of difunctional intercalants: n-ketoesters, n-ketoacids and n-ketophosphatidylcholines. The present study initiates a comparable study of bioliposomes and erythrocyte ghosts. This required the (13)C NMR characterization of these systems for the first time, and further involved a determination of the signals of three doubly (13)C-labeled intercalants, in particular, n-ketophosphatidylcholines where n=4, 8 and 12. This study reveals that DMPC liposomes, bioliposomes and erythrocyte ghosts, with all their structural differences, are not radically different from the perspective of polarity gradient. Any differences observed reflect the additives often naturally present in these lipid systems.


Subject(s)
Erythrocyte Membrane/chemistry , Lipid Bilayers/chemistry , Liposomes/chemistry , Magnetic Resonance Spectroscopy , Coumarins/chemistry , Dimyristoylphosphatidylcholine/chemistry , Intercalating Agents/chemistry , Microscopy, Fluorescence , Thermodynamics
2.
Melanoma Res ; 19(4): 203-10, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19478684

ABSTRACT

The phosphatase and tensin homolog (PTEN) exerts its function, in part, by negatively regulating the well-known phosphatidylinositol-3-kinase/AKT signaling pathway. Previous histological work has suggested that alterations in the nuclear/cytoplasmic compartmentalization of PTEN may play a role in the development and progression of melanoma. In this study, we examined the nuclear/cytoplasmic compartmentalization of PTEN in melanoma cell lines and its correlation with the cell cycle. Studies were performed in melanoma cells lines using classic cell biological techniques. In contrast to breast cancer cell lines, we found that increased levels of nuclear PTEN levels correlate with G2 rather than with G1 arrest. In WM164 and SKmel28 cells, overexpression of PTEN protein did not significantly increase the number of cells in the G2 phase. Differential CDC2 phosphorylation levels in cells that overexpressed PTEN compared with those where PTEN was downregulated suggest some involvement of PTEN in G2 checkpoint regulation. The data suggest that although nuclear PTEN levels correlate with the G2 phase, the role of PTEN in modulating G2/M arrest is not limiting. Further, the specific cell cycle phase regulated by nuclear PTEN is cell-type dependent. Taken together, our observations suggest that in melanoma, nuclear PTEN is involved in G2 progression possibly through the modulation of CDC2, opening up a new arena for investigation.


Subject(s)
G2 Phase , Melanoma/physiopathology , PTEN Phosphohydrolase/metabolism , CDC2 Protein Kinase/metabolism , Cell Compartmentation , Cell Cycle , Cell Line, Tumor , Cell Nucleus/metabolism , Cytoplasm/metabolism , Down-Regulation , Gene Expression Regulation, Neoplastic , Humans , PTEN Phosphohydrolase/genetics , Phosphorylation , Poly(ADP-ribose) Polymerases/metabolism , Protein Biosynthesis , RNA Interference
SELECTION OF CITATIONS
SEARCH DETAIL